Gallium-Containing Bioactive Glasses: Their Influence on Ion Release and the Bioactivity of Resulting Glass Polyalkenoate Cements
Source abstract
Abstract
A series of glasses (0.48SiO2 − [0.40-x]ZnO − 0.12CaO-xGa2O3, x = 0, 0.8, 0.16) was developed to formulate a series of Ga-containing glass polyalkenoate cements (GPCs). The solubility of GPCs was tested using DI water, and it was found that the sample containing the highest mol% of Ga, LGa-2, had the most Ga ion release. The GPCs were incubated in SBF, and SEM/EDS analysis revealed that the at% of P increased, while the at% of Si decreased, highlighting the CaP precipitation on the GPC surface. The at% of Ga also decreased, reinforcing the Ga release from the GPC. Cellular testing against fibroblasts and osteoblasts showed that a concentration of 25 mg/mL of the liquid extracts from the LGa-2 GPC had increased cell viability compared to other concentrations and GPCs tested. Antibacterial studies against E. coli and S. epidermidis demonstrated inhibition zones around the GPCs, highlighting their effectiveness in the elimination of bacteria on contact.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Inamori School of Engineering, Alfred University, Alfred, NY 14802, USA
Chemical and Biochemical Engineering, Missouri University of Science and Technology, Rolla, MO 65409, USA
References (63)
Show source-provided references
1. A review of glass ionomer restorations in the primary dentition
2. The use of glass ionomer cements in both conventional and surgical endodontics10.1111/j.0143-2885.2004.00769.x ↗
3. Szoradi, G.T., Feier, A.M., Zuh, S.G., Russu, O.M., and Pop, T.S. (2024). Polymethyl Methacrylate bone cement polymerization induced thermal necrosis at the cement–bone interface: A narrative review. Appl. Sci., 14.10.3390/app142411651 ↗
4. Glass Ionomer Polyalkenoate Cements and related materials: Past, present and future10.1038/s41415-022-4239-1 ↗
5. Can glass polyalkenoate (glass ionomer) dental cements be considered bioactive? A review10.1016/j.heliyon.2024.e25239 ↗
6. Chemically activated glass ionomer cements as bioactive materilas in dentistry: A review10.3390/prosthesis5010024 ↗
7. Effect of bioactive glass incorporation into glass ionomer cement on demineralized dentin10.1038/s41598-021-86481-y ↗
8. Role of exchanged ions in the integration of ionomeric (glass polyalkenoate) bone substitutes10.1016/S0142-9612(96)00150-0 ↗
9. Ion processes in glass ionomer cements10.1016/j.jdent.2005.09.008 ↗
10. Glass-ionomer cements as adhesives10.1007/BF00120376 ↗
11. Böker, K.O., Richter, K., Jäckle, K., Taheri, S., Grunwald, I., Borcherding, K., von Byern, J., Hartwig, A., Wildemann, B., and Schilling, A.F. (2019). Current State of Bone Adhesives—Necessities and Hurdles. Materials, 12.10.3390/ma12233975 ↗
12. Hatton, P.V., Kearns, V.R., and Brook, I.M. (2008). Bone–cement fixation: Glass–ionomer cements. J. Rep. Tech., 252–263.10.1533/9781845694807.2.252 ↗
13. Zinc-based glass polyalkenoate cements with improved setting times and mechanical properties10.1016/j.actbio.2007.07.010 ↗
14. The role of Sr2+ on the structure and reactivity of SrO-CaO-ZnO-SiO2 ionomer glasses10.1007/s10856-006-0060-7 ↗
15. A Spectroscopic investigation into the setting and mechanical properties of titanium containing glass ionomer cements10.1007/s10856-010-4089-2 ↗
16. The effect of Strontium oxide in glass ionomer cements10.1023/A:1008944924726 ↗
17. Evaluation of two novel aluminum-free, zinc-based glass polyalkenoate cements as alternatives to PMMA bone cement for use in vertebroplasty and balloon kyphoplasty10.1007/s10856-009-3845-7 ↗
18. Copper-containing glass polyalkenoate cements based on SiO2–ZnO–CaO–SrO–P2O5 glasses: Glass characterization, physical and antibacterial properties10.1007/s10853-017-0945-5 ↗
19. Zinc, a new coherent therapy for osteoporosis10.1007/s002230001138 ↗
20. Myoclonic encephalopathy after exposure to aluminium
21. Subacute fatal aluminium encephalopathy after reconstructive otoneurosurgery: A Case Report10.1053/hupa.2001.28251 ↗
22. Bush, A. (2004). Aluminium and Alzheimers Disease. Alzheimer’s Aust., 1–5.
23. Aluminium toxicity perturbs long bone calcification in the embryonic chick10.1007/s002040050674 ↗
24. Biocompatability of glass ionomer bone cements10.1016/j.jdent.2004.10.027 ↗
25. Development of glass-ionomer cement systems10.1016/S0142-9612(97)00126-9 ↗
26. Influence of poly(acrylic acid) molar mass on the fracture properties of glass polyalkenoate cements10.1023/A:1004498217028 ↗
27. A review of powder modifications in conventional glass-ionomer dental cements10.1039/C0JM02309D ↗
28. Growth and differentiation of osteoblastic cells on 13-93 bioactive glass fibers and scaffolds10.1016/j.actbio.2007.07.006 ↗
29. Surface functionalization of Bioglass®-derived porous scaffolds10.1016/j.actbio.2007.01.008 ↗
30. 45S5 Bioglass®-derived glass-ceramic scaffolds for bone tissue engineering10.1016/j.biomaterials.2005.11.025 ↗
31. The story of Bioglass10.1007/s10856-006-0432-z ↗
32. Glass ionomer cements with enhanced mechanical and remineralizing properties containing 45S5 bioglass-ceramic particles10.1016/j.jmbbm.2019.05.033 ↗
33. Wound dressings composed of copper-doped borate bioactive glass microfibers stimulate angiogenesis and heal full-thickness skin defects in a rodent model10.1016/j.biomaterials.2015.02.112 ↗
34. Compressive strength and surface characterization of glass ionomer cements modified by particles of bioactive glass10.1016/j.dental.2004.03.006 ↗
35. Devitrification of ionomer glass and its effect on the in vitro biocompatability of glass ionomer cements10.1016/S0142-9612(03)00124-8 ↗
36. Glass ionomer cements: A review of composition, chemistry, and biocompatibility as a dental and medical implant material10.1615/JLongTermEffMedImplants.v15.i6.80 ↗
37. Characterization and in vitro bioactivity of zinc-containing bioactive glass and glass-ceramics10.1177/0885328206054535 ↗
38. Role of endogenous zinc in the enhancement of bone protein synthesis associated with bone growth of newborn rats10.1007/s007740170058 ↗
39. In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi10.1016/j.vetmic.2010.05.027 ↗
40. Increasing the antibacterial activity of gallium(III) against Pseudomonas aeruginosa upon coordination to pyridine-derived thiosemicarbazones10.1016/j.poly.2009.04.022 ↗
41. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity10.1172/JCI30783 ↗
42. Controlled delivery of antimicrobial gallium ions from phosphate-based glasses10.1016/j.actbio.2008.09.019 ↗
43. Medical applications and toxicities of gallium compounds10.3390/ijerph7052337 ↗
44. Important advances in oncology10.1097/00001813-199108000-00014 ↗
45. Gallium in cancer treatment10.1016/S1040-8428(01)00225-6 ↗
46. Nuclear microprobe imaging of gallium nitrate in cancer cells10.1016/S0168-583X(03)01052-8 ↗
47. Coordination to gallium(III) strongly enhances the potency of 2-pyridineformamide thiosemicarbazones against Cryptococcus opportunistic fungi10.1016/j.micres.2009.10.005 ↗
48. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages10.1128/IAI.68.10.5619-5627.2000 ↗
49. Gallium increases bone calcium and crystallite perfection of hydroxyapatite10.1007/BF02555174 ↗
50. Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts10.1111/j.1476-5381.2010.00665.x ↗
51. Gallium nitrate increases type I collagen and fibronectin mRNA and collagen protein levels in bone and Fibroblast cells10.1002/jcb.240520404 ↗
52. Metabolic effects of gallium nitrate administration by prolonged infusion
53. Antitumor activity and toxicity of salts of inorganic group IIIa metals: Aluminum, Gallium, Indium, and Thallium10.1073/pnas.68.7.1623 ↗
54. Phase 2 Multicenter trial of gallium nitrate in patients with advanced non-Hodgkin’s Lymphoma10.1182/blood.V104.11.2487.2487 ↗
55. Gallium nitrate in advanced bladdercarcinoma: Southwest oncology group study10.1016/0090-4295(91)80152-W ↗
56. Low-dose gallium ntrate for prevention of osteolysis in myeloma: Results of a pilot randomized study10.1200/JCO.1993.11.12.2443 ↗
57. Phase II trial of vinblastine, Ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma10.1200/JCO.1994.12.11.2271 ↗
58. A randomized double-blind study of gallium nitrate compared with Etidronate for acute control of cancer-related hypercalcemia10.1200/JCO.1991.9.8.1467 ↗
59. Randomized, double-blind, phase II trial of gallium nitrate compared with Pamidronate for acute control of cancer-related hypercalcemia
60. (2003). Biological Evaluation of Medical Devices (Standard No. ISO10993).
61. Gallium containing glass polyalkenoate anti-cancerous bone cements: Glass characterization and physical properties10.1007/s10856-012-4624-4 ↗
62. The impact of gallium content on degradation, bioactivity, and antibacterial potency of zinc borate bioactive glass10.1002/jbm.b.33856 ↗
63. Gao, Z., Song, M., Liu, R.L., Shen, Y., Ward, L., Cole, I., Chen, X.B., and Liu, X. (2019). Improving in vitro and in vivo antibacterial functionality of Mg alloys through micro-alloying with Sr and Ga. Mater. Sci. Eng. C Mater. Biol. Appl., 104.10.1016/j.msec.2019.109926 ↗